2015

29 April 2015
Medicure Reports Financial Results for the First Quarter of 2015

27 April 2015
Medicure Q1 Results and Conference Call Dates

23 April 2015
Medicure Announces Approval of Expanded Dosing Time For AGGRASTAT®

22 April 2015
Medicure to Present at the 2015 Bloom Burton & Co. Healthcare Conference

14 April 2015
Medicure Reports Financial Results for the Seven Months Ended December 31, 2014

27 March 2015
Medicure Announces Grant of Options

20 March 2015
Medicure Announces Issuance of Shares Under Previously Announced Shares for Debt Settlement

2 February 2015
Medicure Provides Quarterly Revenue on a Calendar Basis Following Change to Year End

27 January 2015
Medicure Announces Shares for Debt Settlements

 





2014


18 December 2014
Medicure Announces Change in Fiscal Year End and Provides One-Time Guidance on Quarterly Revenue

5 November 2014
Dr. Albert Friesen to File Early Warning Report

16 October 2014
Medicure Reports Financial Results for the First Quarter Fiscal 2015

10 September 2014
Medicure Reports Financial Results for Fiscal 2014

13 August 2014
Medicure Provides Update on Tardoxal and Tend-Td Study

11 July 2014
Medicure Announces Shares for Debt Settlement

7 July 2014
Medicure Announces Grant of Options

3 July 2014
Medicure Acquires Minority Position in Pharmaceutical Manufacturer, Apicore

15 April 2014
Medicure Comments on Recent Trading Activity

14 April 2014
Medicure Engages Knight Therapeutics Inc. to Provide Advisory Services

26 March 2014
Medicure Reports Third Quarter Financial Results for Fiscal 2014

28 January 2014
Medicure Reports Second Quarter Results for Fiscal 2014





2013


11 October 2013
Medicure Reports First Quarter Financial Results for Fiscal 2014

11 October 2013
Medicure Announces Approval for Recommended Dosing Regimen for Aggrastat®

27 September 2013
Medicure Reports Financial Results for Fiscal 2013

29 April 2013
Medicure Reports Third Quarter Financial Results for Fiscal 2013

28 February 2013
Dr. Albert D. Friesen to File Early Warning Report

28 January 2013
Medicure Reports Second Quarter Financial Results for Fiscal 2013

22 January 2013
Medicure Appoints Brent Fawkes to Board of Directors

8 January 2013
Medicure Announces Filing of sNDA for Aggrastat Label Change